According to news in ClinicalTrialToday, ASKA, a Canada based CRO, expanding its operations into asia-pacific region through stretgic partnership with a Japanese CRO ASKLEP. 

The partnership with ASKLEP will allow ASKA to create a presence in Japan while helping ASKLEP advance in North America. ASKLEP, which is expanding into other parts of Asia, will do all the on-the-ground work in Japan and Asia while ASKA manages North America.

This is the third partnership of its kind for ASKA, which has similar agreements with Harrison Clinical Research Group in Munich, Germany, and CTI Clinical Trial and Consulting Services in Cincinnati, Ohio. 

ASKA is also working on structuring an alliance with a CRO in Australia and New Zealand and looking for partners in India and in South America, CEO & Founder of ASKA, Valerie Willetts said.

“We’re just testing the waters with a group in India. Before we sign any agreements, we like to test the waters and work together on a clinical trial. So far it’s looking very promising,” she said.

Read Full Story